Literature DB >> 10205210

Vicia faba agglutinin, the lectin present in broad beans, stimulates differentiation of undifferentiated colon cancer cells.

M Jordinson1, I El-Hariry, D Calnan, J Calam, M Pignatelli.   

Abstract

BACKGROUND: Dietary lectins can alter the proliferation of colonic cells. Differentiation is regulated by adhesion molecules which, being glycosylated, are targets for lectin binding. AIMS: To examine the effects of dietary lectins on differentiation, adhesion, and proliferation of colorectal cancer cells.
METHODS: Differentiation was assessed in three dimensional gels, adhesion by aggregation assay, and proliferation by 3H thymidine incorporation. The role of the epithelial cell adhesion molecule (epCAM) was studied using a specific monoclonal antibody in blocking studies and Western blots. The human colon cancer cell lines LS174T, SW1222, and HT29 were studied.
RESULTS: The cell line LS174T differentiated in the presence of Vicia faba agglutinin (VFA) into gland like structures. This was inhibited by anti-epCAM monoclonal antibody. Expression of epCAM itself was unaffected. VFA as well as wheat germ agglutinin (WGA) and the edible mushroom lectin (Agaricus bisporus lectin, ABL) significantly aggregated LS174T cells but peanut agglutinin (PNA) and soybean agglutinin (SBA) did not. All lectins aggregated SW1222 and HT29 cells. Aggregation was blocked by the corresponding sugars. Aggregation of cells by VFA was also inhibited by anti-epCAM. VFA, ABL, and WGL inhibited proliferation of all the cell lines; PNA stimulated proliferation of HT29 and SW1222 cells. In competition studies all sugars blocked aggregation and proliferation of all cell lines, except that the addition of mannose alone inhibited proliferation.
CONCLUSION: VFA stimulated an undifferentiated colon cancer cell line to differentiate into gland like structures. The adhesion molecule epCAM is involved in this. Dietary or therapeutic VFA may slow progression of colon cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205210      PMCID: PMC1727505          DOI: 10.1136/gut.44.5.709

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  A differential response elicited in macrophages on interaction with lectins.

Authors:  R Goldman; N Sharon; R Lotan
Journal:  Exp Cell Res       Date:  1976-05       Impact factor: 3.905

2.  Influence of lectins on the binding of 125I-labeled EGF to human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  Biochem Biophys Res Commun       Date:  1977-11-21       Impact factor: 3.575

Review 3.  Carcinoembryonic antigens and related glycoproteins. Molecular aspects and specificity.

Authors:  G T Rogers
Journal:  Biochim Biophys Acta       Date:  1983-12-29

Review 4.  Lectins in the United States diet: a survey of lectins in commonly consumed foods and a review of the literature.

Authors:  M S Nachbar; J D Oppenheim
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

5.  Identification of the dietary lectin, wheat germ agglutinin, in human intestinal contents.

Authors:  P G Brady; A M Vannier; J G Banwell
Journal:  Gastroenterology       Date:  1978-08       Impact factor: 22.682

6.  Biosynthesis of the epidermal growth factor receptor in cultured human cells.

Authors:  C M Stoscheck; A M Soderquist; G Carpenter
Journal:  Endocrinology       Date:  1985-02       Impact factor: 4.736

7.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

8.  Peanut ingestion increases rectal proliferation in individuals with mucosal expression of peanut lectin receptor.

Authors:  S D Ryder; M R Jacyna; A J Levi; P M Rizzi; J M Rhodes
Journal:  Gastroenterology       Date:  1998-01       Impact factor: 22.682

9.  Longitudinal karyotype and genetic signature analysis of cultured human colon adenocarcinoma cell lines LS180 and LS174T.

Authors:  L P Rutzky; C I Kaye; M J Siciliano; M Chao; B D Kahan
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

Review 10.  The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions.

Authors:  U Rutishauser; A Acheson; A K Hall; D M Mann; J Sunshine
Journal:  Science       Date:  1988-04-01       Impact factor: 47.728

View more
  11 in total

1.  Direct targeting of cancer cells: a multiparameter approach.

Authors:  Eileen L Heinrich; Lily Anne Y Welty; Lisa R Banner; Steven B Oppenheimer
Journal:  Acta Histochem       Date:  2005-09-21       Impact factor: 2.479

2.  Stress-induced phosphorylation of caveolin-1 and p38, and down-regulation of EGFr and ERK by the dietary lectin jacalin in two human carcinoma cell lines.

Authors:  Anagh A Sahasrabuddhe; Neesar Ahmed; M V Krishnasastry
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

3.  A novel core fucose-specific lectin from the mushroom Pholiota squarrosa.

Authors:  Yuka Kobayashi; Hiroaki Tateno; Hideo Dohra; Kenta Moriwaki; Eiji Miyoshi; Jun Hirabayashi; Hirokazu Kawagishi
Journal:  J Biol Chem       Date:  2012-08-07       Impact factor: 5.157

4.  Lectin histochemistry as a predictor of dysplasia grade in colorectal adenomas.

Authors:  A C Lazaris ; E B Chatzigianni ; H Paraskevakou ; S Tseleni-Balafouta ; P S Davaris
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

5.  Modulation of PP2A activity by Jacalin: is it through caveolae and ER chaperones?

Authors:  Neesar Ahmed; Satyabrata Pany; Aejazur Rahman; Saumya S Srivastava; Amita Sneh; Musti V Krishnasastry
Journal:  Glycoconj J       Date:  2009-10-13       Impact factor: 2.916

6.  Characterization of lectins and their specificity in carcinomas-An appraisal.

Authors:  Asma Farhat Sherwani; Sameena Mohmood; Fauzia Khan; Rizwan Hasan Khan; Md Asim Azfer
Journal:  Indian J Clin Biochem       Date:  2003-07

7.  Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies.

Authors:  Karineh Petrossian; Lisa R Banner; Steven B Oppenheimer
Journal:  Acta Histochem       Date:  2007-08-16       Impact factor: 2.479

8.  Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

Authors:  P Went; M Vasei; L Bubendorf; L Terracciano; L Tornillo; U Riede; J Kononen; R Simon; G Sauter; P A Baeuerle
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640

Review 9.  Use of proteins as biomarkers and their role in carcinogenesis.

Authors:  Paul Zarogoulidis; Kosmas Tsakiridis; Chrisanthi Karapantzou; Sofia Lampaki; Ioannis Kioumis; Georgia Pitsiou; Antonis Papaiwannou; Wolfgang Hohenforst-Schmidt; Haidong Huang; George Kesisis; Ilias Karapantzos; Serafeim Chlapoutakis; Ippokratis Korantzis; Andreas Mpakas; Vasilis Karavasilis; Ioannis Mpoukovinas; Qiang Li; Konstantinos Zarogoulidis
Journal:  J Cancer       Date:  2015-01-01       Impact factor: 4.207

Review 10.  Plant Lectins as Medical Tools against Digestive System Cancers.

Authors:  Laura Elena Estrada-Martínez; Ulisses Moreno-Celis; Ricardo Cervantes-Jiménez; Roberto Augusto Ferriz-Martínez; Alejandro Blanco-Labra; Teresa García-Gasca
Journal:  Int J Mol Sci       Date:  2017-07-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.